midazolam has been researched along with Anomalous Ventricular Excitation Syndrome in 5 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Anesthesia was induced with alfentanil (50 micrograms/kg), midazolam (0." | 9.08 | Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia. ( Dobkowski, WB; Klein, G; Murkin, JM; Sharpe, MD; Yee, R, 1995) |
| "The effects of alfentanil-midazolam anaesthesia upon the electrophysiologic (EP) properties of normal atrioventricular (A-V) and accessory pathway (AP) conduction were studied in eight patients with Wolff-Parkinson-White syndrome during accessory pathway surgical ablation." | 7.68 | Alfentanil-midazolam anaesthesia has no electrophysiological effects upon the normal conduction system or accessory pathways in patients with Wolff-Parkinson-White syndrome. ( Dobkowski, WB; Guiraudon, G; Klein, G; Murkin, JM; Sharpe, MD; Yee, R, 1992) |
| "Sevoflurane was administered to achieve an end-tidal concentration of 2% (1 minimum alveolar concentration), and the study measurements were repeated." | 6.69 | Sevoflurane has no effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia. ( Basta, M; Cuillerier, DJ; Klein, GJ; Krahn, AD; Lee, JK; Sharpe, MD; Yee, R, 1999) |
| " Anesthesia was induced with alfentanil (50 micrograms/kg), midazolam (0." | 5.08 | Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia. ( Dobkowski, WB; Klein, G; Murkin, JM; Sharpe, MD; Yee, R, 1995) |
| "The effects of alfentanil-midazolam anaesthesia upon the electrophysiologic (EP) properties of normal atrioventricular (A-V) and accessory pathway (AP) conduction were studied in eight patients with Wolff-Parkinson-White syndrome during accessory pathway surgical ablation." | 3.68 | Alfentanil-midazolam anaesthesia has no electrophysiological effects upon the normal conduction system or accessory pathways in patients with Wolff-Parkinson-White syndrome. ( Dobkowski, WB; Guiraudon, G; Klein, G; Murkin, JM; Sharpe, MD; Yee, R, 1992) |
| "Sevoflurane was administered to achieve an end-tidal concentration of 2% (1 minimum alveolar concentration), and the study measurements were repeated." | 2.69 | Sevoflurane has no effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia. ( Basta, M; Cuillerier, DJ; Klein, GJ; Krahn, AD; Lee, JK; Sharpe, MD; Yee, R, 1999) |
| "The management of Ebstein's anomaly is based on its severity." | 1.35 | [Anesthetic management for repair of Ebstein's anomaly with WPW syndrome]. ( Kawahito, S; Kawano, H; Kitahata, H; Nakamura, T; Okada, T; Oshita, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Landsem, LM | 1 |
| Ross, FJ | 1 |
| Eisses, MJ | 1 |
| Nakamura, T | 1 |
| Kawahito, S | 1 |
| Kawano, H | 1 |
| Okada, T | 1 |
| Kitahata, H | 1 |
| Oshita, S | 1 |
| Sharpe, MD | 3 |
| Dobkowski, WB | 2 |
| Murkin, JM | 2 |
| Klein, G | 2 |
| Yee, R | 3 |
| Cuillerier, DJ | 1 |
| Lee, JK | 1 |
| Basta, M | 1 |
| Krahn, AD | 1 |
| Klein, GJ | 1 |
| Guiraudon, G | 1 |
2 trials available for midazolam and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia.
Topics: Adolescent; Adult; Alfentanil; Anesthesia; Atrioventricular Node; Catheter Ablation; Electrophysiolo | 1995 |
Sevoflurane has no effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia.
Topics: Adult; Alfentanil; Anesthetics, Inhalation; Anesthetics, Intravenous; Atrioventricular Node; Cathete | 1999 |
3 other studies available for midazolam and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
A case of midazolam anaphylaxis during a pediatric patient's first anesthetic.
Topics: Adolescent; Anaphylaxis; Anesthesia, General; Calcium Chloride; Cardiopulmonary Resuscitation; Cathe | 2017 |
[Anesthetic management for repair of Ebstein's anomaly with WPW syndrome].
Topics: Adult; Anesthesia; Arrhythmias, Cardiac; Child, Preschool; Ebstein Anomaly; Echocardiography, Transe | 2009 |
Alfentanil-midazolam anaesthesia has no electrophysiological effects upon the normal conduction system or accessory pathways in patients with Wolff-Parkinson-White syndrome.
Topics: Adult; Alfentanil; Anesthesia, Intravenous; Atrial Function, Right; Atrioventricular Node; Blood Pre | 1992 |